LAG3 (CD223) as a cancer immunotherapy target-Reference-Cited by-同舟云学术

LAG3 (CD223) as a cancer immunotherapy target

Published:2017-03 Issue:1 Volume:276 Page:80-96
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

Andrews Lawrence P.¹,Marciscano Ariel E.²,Drake Charles G.³,Vignali Dario A. A.¹⁴

Affiliation:

1. Department of Immunology; University of Pittsburgh School of Medicine; Pittsburgh PA USA

2. Department of Radiation Oncology & Molecular Radiation Sciences; Sidney Kimmel Comprehensive Cancer Center; The Johns Hopkins School of Medicine; Baltimore MD USA

3. Departments of Oncology, Immunology and Urology; Sidney Kimmel Comprehensive Cancer Center; The Johns Hopkins School of Medicine; Baltimore MD USA

4. Tumor Microenvironment Center; University of Pittsburgh Cancer Institute; Pittsburgh PA USA

Funder

National Institutes of Health

NCI Comprehensive Cancer Center Support CORE

Melanoma Research Association

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12519/fullpdf

Reference100 articles.

1. Reversing T-cell Dysfunction and Exhaustion in Cancer;Zarour;Clin Cancer Res,2016

2. Redefining chronic viral infection;Virgin;Cell,2009

3. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival;Curiel;Nat Med,2004

4. Regulatory T cells in tumor immunity;Nishikawa;Int J Cancer,2010

5. Breakthrough of the year 2013. Cancer immunotherapy;Couzin-Frankel;Science,2013

Cited by 693 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus;Journal of Translational Autoimmunity;2024-12

2. Baseline sLAG-3 levels in Caucasian and African-American breast cancer patients;Breast Cancer Research and Treatment;2024-09-04

3. Progesterone receptor impairs immune respond and down-regulates sensitivity to anti-LAG3 in breast cancer;Translational Research;2024-09

4. Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis;The Journal of Molecular Diagnostics;2024-09

5. Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy;iScience;2024-09